Mary Rozenman – Biography
Last update: February 26, 2026Executive profile
Mary was Senior Vice President of Corporate Development and Strategy at Aimmune Therapeutics, and Vice President at Longitude Capital.
Mary Rozenman is currentlyChief Financial Officer and Chief Business Officer at Insitro - View - Insitro org chart
Director at Tessera Therapeutics - View - Tessera Therapeutics org chart
Create your alert
to follow the career of Mary Rozenman.
Education
Mary Rozenman has a Bachelor of Arts in Biochemistry and Russian literature from Columbia University and a Doctorate in Organic Chemistry and Chemical Biology from Harvard University.
They have also studied at Columbia University :
Find more alumni from Columbia University
They have also studied at Harvard University :
Find more alumni from Harvard University
More about Mary Rozenman
Selected links
Do you need to know more about Mary Rozenman? More results.
Participate
Social media
- Mary Rozenman on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Mary Rozenman
The colleagues of Mary Rozenman
Company Colleagues
- At Insitro, Mary Rozenman has 44 colleagues including Daphne Koller (CEO & Founder), Roger Perlmutter (Director)…
- At Tessera Therapeutics, Mary Rozenman has 23 colleagues including Michael Severino (CEO & Director), Paul Biondi (Director)…
Industry Colleagues
- In the Biotechnology industry, Mary Rozenman has 35,763 colleagues in 2,407 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Mary Rozenman.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Mary Rozenman.
